Three New Cancer Projects Receive Funding in Joint Collaboration Between Oden Institute, MD Anderson's IDSO and TACC
The University of Texas MD Anderson Cancer Center, the Oden Institute for Computational Engineering and Sciences, and the Texas Advanced Computing Center (TACC) at The University of Texas at Austin have announced funding for three cancer research projects as part of the Joint Center for Computational Oncology (JCCO).
This collaborative initiative continues to accelerate breakthroughs in oncology by combining the Oden Institute’...
MD Anderson and HealthEx announce collaboration to develop new platform to give patients direct control of data access
The University of Texas MD Anderson Cancer Center and HealthEx today announced a strategic collaboration aimed at developing tools for...
AACR: HER2 targeted therapy shows promise in previously treated lung cancers
Zongertinib, a HER2-targeted therapy made by Boehringer Ingelheim, demonstrated promising results in HER2-mutant lung cancer.
...
...
MD Anderson researchers develop novel antibody-toxin conjugate
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. According to preclinical results published today in Nature Cancer, the new approach combined the benefits of more well-known antibody-drug conjugates (ADCs) with those of immunotherapies.
ADCs have emerged as a breakthrough in recent years due to their...
